News
Stay informed with the latest M&A insights, industry trends, and thought leadership from Translink Corporate Finance. Our expert commentary and deal updates keep clients and partners ahead in an evolving financial landscape.
Industrials Of The Future Report: 2050
Uncertainty about the future has dominated headlines in the last two years. On a global level, the COVID-19-related restrictions and, more recently, the Russia/Ukraine war have resulted in ripple effects and, in some cases, tsunamis that will be felt far into the future. The longer-term extent of these knock-on effects is unknown. Futurists therefore dedicate their work to scenario planning, to imagine plausible futures based on the so-called ‘known unknowns’. This is exactly what Translink and the Institute for Futures Research (IFR) has explored in the first of five sector reports entitled Tomorrow : 2050 Alternative Futures. The first iteration focuses on the futures of industrials.
Translink Advised The Oncology Institute of Hope & Innovation In The Acquisition Of Women’s Cancer Care
The Oncology Institute of Hope and Innovation (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, recently acquired Women’s Cancer Care, the practice of Christopher R. Perkins, M.D. and Lisa Ge, M.D. Established in 2001, Women’s Cancer Care is the only clinic between San Francisco and Los Angeles specializing in breast and gynecology oncology patients. The acquisition will expand TOI’s footprint north into Fresno, California.
Translink Advised Pharma-insight On The 100% Sale To M3 Inc.
Translink Corporate Finance in Germany advised pharma-insight on the 100% sale to M3 Inc. pharma-insight delivers a comprehensive portfolio of market research services to the life sciences industry. This includes access to their dedicated healthcare panel, the addition of which further strengthens M3’s proprietary healthcare professional panel, which is the largest in the world.
Translink Advised Peak Proteins On The 100% Sale To Sygnature Discovery
Translink Corporate Finance in the UK advised a rapidly growing contract research organisation, Peak Proteins, on the 100% sale to a leading independent integrated drug discovery and non-clinical services company, Sygnature Discovery.
Translink Advised JCommerce In The 100% Sale To Inetum Group
Translink Corporate Finance’s partner in Poland, Holon, together with Translink France acted as the advisors to Polish company, JCommerce, in the 100% sale to international provider of broad-spectrum IT solutions, Inetum Group in France.
Translink advised EN Engineering in the acquisition of TG Advisers, Inc.
EN Engineering (“EN”) announced the acquisition of steam and gas turbine, generator, and utility plant consultants,,TG Advisers, Inc.
What ESG Means For A Future-Fit M&A Industry
ESG (Environment Sustainability and Governance) has become an essential concern for deal-making, primarily driven by consumer and investor demand. Now, there are also critical legislative considerations from a myriad of countries. In the move to a stakeholder-centric model, there’s even greater focus on ESG integration, with entire supply chains being assessed. Going forward, we can expect robust ESG frameworks with a host of measurable metrics that will play a big role in acquisition decision-making.
Translink Partner In Poland, Holon, Advises Bocian Clinic On The Acquisition Of Ab ovo
Translink Corporate Finance’s partner in Poland, Holon CF, acted as the advisor to one of the nation’s largest diagnosis and treatment of infertility networks, Klinika Bocian, in acquiring 100% of the shares of Lublin-based infertility treatment clinic, Ab ovo.Translink International AG
